NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Ulcerative colitis
Date of first enrollment	25/05/2010
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : AJG501 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : oral control material(s) Generic name etc : Mesalazine tablet INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : oral

Outcome(s)

Primary Outcome	Change in Revised Sutherland DAI Revised Sutherland DAI
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 16age old
Age maximum	<= 64age old
Gender	Both
Include criteria	Baseline Revised Sutherland DAI score of 4-8 including abnormal rectal bleeding score
Exclude criteria